ZA868104B - Dihydropyridines - Google Patents
DihydropyridinesInfo
- Publication number
- ZA868104B ZA868104B ZA868104A ZA868104A ZA868104B ZA 868104 B ZA868104 B ZA 868104B ZA 868104 A ZA868104 A ZA 868104A ZA 868104 A ZA868104 A ZA 868104A ZA 868104 B ZA868104 B ZA 868104B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydropyridines
- ch2c
- ch2ch
- methoxyethyl
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858526411A GB8526411D0 (en) | 1985-10-25 | 1985-10-25 | Dihydropyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA868104B true ZA868104B (en) | 1988-06-29 |
Family
ID=10587282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA868104A ZA868104B (en) | 1985-10-25 | 1986-10-24 | Dihydropyridines |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0221720B1 (ko) |
| JP (1) | JPS62106077A (ko) |
| KR (1) | KR870003985A (ko) |
| AT (1) | ATE54139T1 (ko) |
| AU (1) | AU6436386A (ko) |
| DE (1) | DE3672252D1 (ko) |
| DK (1) | DK509186A (ko) |
| FI (1) | FI864328A (ko) |
| GB (1) | GB8526411D0 (ko) |
| HU (1) | HUT42443A (ko) |
| IL (1) | IL80402A0 (ko) |
| PT (1) | PT83599B (ko) |
| ZA (1) | ZA868104B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601382D0 (en) * | 1986-01-21 | 1986-02-26 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
| IT1213555B (it) * | 1986-12-11 | 1989-12-20 | Boehringer Biochemia Srl | 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono. |
| JP4465536B2 (ja) | 2007-06-13 | 2010-05-19 | Ｓｍｃ株式会社 | 電磁弁 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
| US4568677A (en) * | 1983-07-23 | 1986-02-04 | Pfizer Inc. | 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents |
| GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
| FI862343A (fi) * | 1985-06-17 | 1986-12-18 | Warner Lambert Co | Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar. |
-
1985
- 1985-10-25 GB GB858526411A patent/GB8526411D0/en active Pending
-
1986
- 1986-10-21 AT AT86308158T patent/ATE54139T1/de not_active IP Right Cessation
- 1986-10-21 EP EP86308158A patent/EP0221720B1/en not_active Expired - Lifetime
- 1986-10-21 DE DE8686308158T patent/DE3672252D1/de not_active Expired - Lifetime
- 1986-10-22 PT PT83599A patent/PT83599B/pt unknown
- 1986-10-23 IL IL80402A patent/IL80402A0/xx unknown
- 1986-10-23 KR KR860008877A patent/KR870003985A/ko not_active Application Discontinuation
- 1986-10-24 HU HU864483A patent/HUT42443A/hu unknown
- 1986-10-24 ZA ZA868104A patent/ZA868104B/xx unknown
- 1986-10-24 FI FI864328A patent/FI864328A/fi not_active Application Discontinuation
- 1986-10-24 JP JP61253522A patent/JPS62106077A/ja active Pending
- 1986-10-24 AU AU64363/86A patent/AU6436386A/en not_active Abandoned
- 1986-10-24 DK DK509186A patent/DK509186A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62106077A (ja) | 1987-05-16 |
| DK509186A (da) | 1987-04-26 |
| GB8526411D0 (en) | 1985-11-27 |
| PT83599B (en) | 1988-11-10 |
| EP0221720B1 (en) | 1990-06-27 |
| DE3672252D1 (en) | 1990-08-02 |
| EP0221720A3 (en) | 1988-09-21 |
| AU6436386A (en) | 1987-05-14 |
| FI864328A0 (fi) | 1986-10-24 |
| EP0221720A2 (en) | 1987-05-13 |
| IL80402A0 (en) | 1987-01-30 |
| FI864328A (fi) | 1987-04-26 |
| HUT42443A (en) | 1987-07-28 |
| DK509186D0 (da) | 1986-10-24 |
| PT83599A (en) | 1986-11-01 |
| ATE54139T1 (de) | 1990-07-15 |
| KR870003985A (ko) | 1987-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3852266D1 (de) | Azaspirane mit immunmodulierender Wirkung. | |
| DK353385D0 (da) | Fremstilling af 3-acylamino-1-hydroxy-2-azetidinoner og herved forekommende n-hydroxybeskyttelsesgrupper | |
| AU613805B2 (en) | Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same | |
| ATE119774T1 (de) | Imidazopyridinderivate und ihre verwendung. | |
| ES2052897T3 (es) | Nucleosidos didesoxidideshidrocarbociclicos. | |
| DK0382660T3 (da) | Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer | |
| EP0221720A3 (en) | Dihydropyridines | |
| EP0208964A3 (en) | 1,5-benzothiazepine compounds | |
| ATE88997T1 (de) | 1,4-dihydropyridinderivate. | |
| DK0541322T3 (da) | 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet | |
| AU3571684A (en) | Aralkyl (arylethynyl) aralkyl amines and their use as vasodilators and antihypertensives | |
| ES2152927T3 (es) | Derivados de acetidinona utiles en la preparacion de antibioticos de carbapenem. | |
| GR850735B (ko) | ||
| IT1201444B (it) | Fosfonopiridine a loro 1,4-diidroderivati | |
| IT1213440B (it) | 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono. |